Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$17.79 - $30.86 $260,623 - $452,099
-14,650 Reduced 94.21%
900 $16,000
Q4 2023

Feb 14, 2024

BUY
$20.78 - $31.77 $323,129 - $494,023
15,550 New
15,550 $486,000
Q2 2023

Aug 08, 2023

SELL
$17.8 - $25.65 $169,972 - $244,931
-9,549 Reduced 42.66%
12,834 $307,000
Q1 2023

May 12, 2023

BUY
$16.32 - $20.92 $365,290 - $468,252
22,383 New
22,383 $421,000
Q2 2022

Aug 09, 2022

BUY
$13.01 - $27.22 $34,099 - $71,343
2,621 Added 14.83%
20,294 $285,000
Q1 2022

May 16, 2022

BUY
$20.94 - $27.5 $370,072 - $486,007
17,673 New
17,673 $428,000
Q4 2021

Feb 11, 2022

SELL
$16.79 - $27.09 $203,159 - $327,789
-12,100 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$15.78 - $24.77 $188,081 - $295,233
11,919 Added 6585.08%
12,100 $200,000
Q2 2021

Aug 12, 2021

BUY
$19.4 - $27.42 $3,511 - $4,963
181 New
181 $4,000
Q1 2021

May 14, 2021

SELL
$25.02 - $54.99 $3,027 - $6,653
-121 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$41.04 - $56.79 $29,384 - $40,661
-716 Reduced 85.54%
121 $6,000
Q3 2020

Nov 16, 2020

BUY
$36.42 - $57.0 $25,348 - $39,672
696 Added 493.62%
837 $34,000
Q2 2020

Aug 13, 2020

SELL
$39.26 - $52.73 $1,531 - $2,056
-39 Reduced 21.67%
141 $6,000
Q1 2020

May 13, 2020

SELL
$31.65 - $46.87 $399,011 - $590,890
-12,607 Reduced 98.59%
180 $7,000
Q4 2019

Feb 10, 2020

BUY
$36.21 - $51.4 $237,066 - $336,515
6,547 Added 104.92%
12,787 $547,000
Q3 2019

Nov 12, 2019

BUY
$22.22 - $44.01 $138,652 - $274,622
6,240 New
6,240 $224,000
Q2 2018

Aug 13, 2018

SELL
$15.07 - $22.34 $99,462 - $147,444
-6,600 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$22.47 - $32.33 $40,221 - $57,870
1,790 Added 37.21%
6,600 $148,000
Q4 2017

Feb 12, 2018

BUY
$26.84 - $39.14 $29,201 - $42,584
1,088 Added 29.23%
4,810 $144,000
Q3 2017

Nov 07, 2017

BUY
$29.49 - $38.37 $109,761 - $142,813
3,722
3,722 $140,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.